MAX dif skin brightening cream (Hypoallerganic Non greasy) 40g e
₨ 1,498
ادائیگی کے طریقے:
تفصیل
MAXDIF Skin Brightening Cream (40g)
Hypoallergenic, Non-Greasy Formula for Radiant & Even Skin Tone
MAXDIF Skin Brightening Cream is a lightweight, dermatologist-tested formula designed to reduce dark spots, even out skin tone, and enhance brightness. Infused with powerful brightening agents, it helps fade hyperpigmentation, sunspots, and discoloration, giving your skin a healthy, radiant glow.
Key Benefits
✔ Brightens & Evens Skin Tone – Reduces dark spots and hyperpigmentation.
✔ Non-Greasy & Lightweight – Absorbs quickly without leaving a sticky residue.
✔ Hypoallergenic & Gentle – Suitable for sensitive and all skin types.
✔ Deeply Hydrating – Keeps skin soft, smooth, and nourished.
✔ Improves Skin Texture – Enhances skin clarity and radiance.
How to Use
- Apply a small amount to clean, dry skin.
- Gently massage in circular motions until fully absorbed.
- Use twice daily, morning and night, for best results.
- Follow with sunscreen during the day to prevent sun damage.
Important Information
- Dermatologist-tested and free from harsh chemicals.
- Safe for daily use on all skin types.
- Avoid direct contact with eyes; rinse immediately if irritation occurs.
- Patch test recommended for sensitive skin before first use.
MAXDIF Skin Brightening Cream is your go-to solution for a glowing, even-toned complexion, offering effective skin brightening with a non-greasy, hypoallergenic formula!
صارف کے جائزے
متعلقہ مصنوعات
MAYBELLINE NEW YORK FIT me (MATT+PORELESS) + 16H OIL CONTROL SPF22 (120)
اسٹاک میں
MAYBELLINE NEW YORK FIT me (MATT+PORELESS) + 16H OIL CONTROL SPF22 (115)
اسٹاک میں
Simple Moisturizing Facial Wash (Vitamin B5 + E, Pro Amino Acids) 150ml
اسٹاک میں
Simple purifying gel wash(WITCH HAZEL+ZINC ,OIL BUSTING) 150ML
اسٹاک میں
VINCE Eye recovery Serum(reduces dark circles and puffines) 15ml
اسٹاک میں
VINCE Whitening Face wash (Lightnix anti Dullness formula Sulphate free) 120ml
اسٹاک میں


فیڈرز
جائزے
فلٹرز صاف کریںابھی تک کوئی جائزہ نہیں ہے۔